A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...
Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...
News Medical on MSN
Engineered liver tissue model mimics early metabolic liver disease
More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...
News Medical on MSN
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results